VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company VolitionRX Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- VolitionRX Ltd Company Overview
- VolitionRX Ltd Company Snapshot
- VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview
- VolitionRX Ltd - Pipeline Analysis Overview
- VolitionRX Ltd - Key Facts
- VolitionRX Ltd - Major Products and Services
- VolitionRX Ltd Pipeline Products by Development Stage
- VolitionRX Ltd Ongoing Clinical Trials by Trial Status
- VolitionRX Ltd Pipeline Products Overview
- Companion Diagnostic Sepsis
- Companion Diagnostic Sepsis Product Overview
- HyperGenomics Diagnostic Test - Colon Cancer
- HyperGenomics Diagnostic Test - Colon Cancer Product Overview
- HyperGenomics Diagnostic Test - Leukaemia
- HyperGenomics Diagnostic Test - Leukaemia Product Overview
- HyperGenomics Diagnostic Test - Prostate Cancer
- HyperGenomics Diagnostic Test - Prostate Cancer Product Overview
- Nu.Q Assay - Blood Cancer
- Nu.Q Assay - Blood Cancer Product Overview
- Nu.Q COVID-19 Triage Test
- Nu.Q COVID-19 Triage Test Product Overview
- Nu.Q CRC Screening Test
- Nu.Q CRC Screening Test Product Overview
- Nu.Q CRC Screening Test Clinical Trial
- Nu.Q CRC Symptomatic Test
- Nu.Q CRC Symptomatic Test Product Overview
- Nu.Q CRC Triage Test
- Nu.Q CRC Triage Test Product Overview
- Nu.Q Frontline Asymptomatic CRC Screening Test
- Nu.Q Frontline Asymptomatic CRC Screening Test Product Overview
- Nu.Q NETS Assay - Influenza
- Nu.Q NETS Assay - Influenza Product Overview
- Nu.Q NETs Assay Sepsis
- Nu.Q NETs Assay Sepsis Product Overview
- NuQ - A Androgen Receptor Cell Culture ELISA Kit
- NuQ - A Androgen Receptor Cell Culture ELISA Kit Product Overview
- NuQ - A EZH2 Cell Culture ELISA Kit
- NuQ - A EZH2 Cell Culture ELISA Kit Product Overview
- NuQ - A HMGB1 Cell Culture ELISA Kit
- NuQ - A HMGB1 Cell Culture ELISA Kit Product Overview
- NuQ - A Oestrogen Receptor Cell Culture ELISA Kit
- NuQ - A Oestrogen Receptor Cell Culture ELISA Kit Product Overview
- NuQ - A Progesterone Receptor Cell Culture ELISA Kit
- NuQ - A Progesterone Receptor Cell Culture ELISA Kit Product Overview
- NuQ - Prostate Cancer
- NuQ - Prostate Cancer Product Overview
- NuQ Diagnostic Test - Lung Cancer
- NuQ Diagnostic Test - Lung Cancer Product Overview
- NuQ Diagnostic Test - Lung Cancer Clinical Trial
- NuQ Diagnostic Test - Pancreatic Cancer
- NuQ Diagnostic Test - Pancreatic Cancer Product Overview
- NuQ Diagnostic Test - Pancreatic Cancer Clinical Trial
- NuQ Endo
- NuQ Endo Product Overview
- NuQ-B
- NuQ-B Product Overview
- NuQ-IHC
- NuQ-IHC Product Overview
- NuQ-M Gamma - H2AX Cell Culture ELISA Kit
- NuQ-M Gamma - H2AX Cell Culture ELISA Kit Product Overview
- NuQ-M H3K27(Me)3 Cell Culture ELISA Kit
- NuQ-M H3K27(Me)3 Cell Culture ELISA Kit Product Overview
- NuQ-M H4K16(Ac) Cell Culture ELISA Kit
- NuQ-M H4K16(Ac) Cell Culture ELISA Kit Product Overview
- NuQ-M H4K20(Me)3 Cell Culture ELISA Kit
- NuQ-M H4K20(Me)3 Cell Culture ELISA Kit Product Overview
- NuQ-M H4Pan(Ac) Cell Culture ELISA Kit
- NuQ-M H4Pan(Ac) Cell Culture ELISA Kit Product Overview
- NuQ-M Ubiquityl H2A Cell Culture ELISA Kit
- NuQ-M Ubiquityl H2A Cell Culture ELISA Kit Product Overview
- NuQ-V
- NuQ-V Product Overview
- NuQ-V mH2A1.1 Cell Culture ELISA Kit
- NuQ-V mH2A1.1 Cell Culture ELISA Kit Product Overview
- NuQ-V mH2A2 Cell Culture ELISA Kit
- NuQ-V mH2A2 Cell Culture ELISA Kit Product Overview
- NuQ-X Hydroxymethylated DNA Cell Culture Kit
- NuQ-X Hydroxymethylated DNA Cell Culture Kit Product Overview
- NuQ-X Methylated DNA Cell Culture Kit
- NuQ-X Methylated DNA Cell Culture Kit Product Overview
- VolitionRX Ltd - Key Competitors
- VolitionRX Ltd - Key Employees
- VolitionRX Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Kino Biotech Co Ltd
- Epigenomics AG
- SciGen Pte Ltd
- PathGEN Dx Pte. Ltd.
- Ab Sciex Pte Ltd
- Abbott Laboratories